About the TMA
The TMA accelerates medical innovation through strategic support
The University Medicine Zürich (UMZH) brings together world-class researchers and clinicians to deliver breakthrough solutions for patients. The Translational Medicine Accelerator (TMA) has been part of this network since 2021, helping to unlock the innovation potential within our institutions.
The TMA supports researchers and entrepreneurs to critically evaluate their translational ideas, sharpen them into viable commercial products, and advance them through a spinout, industry collaboration, or other partnership.
We welcome all life science researchers across the UMZH network — including UZH, ETH, and all affiliated hospitals.
What does the TMA do?
Support for Entrepreneurs
Provide tailored mentoring, advice and resources to help entrepreneurs transform research ideas into viable ventures
Facilitation of collaborations
Promote partnerships between academia and industry to accelerate innovation by leveraging complementary expertise and resources
Coordination of Expert Networking - SPARK Nights
Organize dedicated events where entrepreneurs present their innovations to external advisors, gaining actionable feedback to refine ideas and expand their network
Co-management of the UZH Life Science Fund (LSF)
Manage the UZH Life Science Fund, a partnership between Novartis Venture Fund and the UZH foundation, by preparing spinouts for the LSF application